▶ 調査レポート

次世代生物製剤の世界市場：市場規模・現状・予測
• 英文タイトル：Global Next-Generation Biologics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。次世代生物製剤の世界市場：市場規模・現状・予測 / Global Next-Generation Biologics Market Size, Status and Forecast 2019-2025 / QYR9ST04977資料のイメージです。• レポートコード：QYR9ST04977
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※当調査レポートでは、次世代生物製剤の世界市場について調査・分析し、次世代生物製剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体、再生医療、インスリン、成長ホルモン、その他）、用途別（医療、科学研究、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の次世代生物製剤市場動向
・主要企業別マーケットシェア
・次世代生物製剤の種類別市場規模2014-2019
（抗体、再生医療、インスリン、成長ホルモン、その他）
・次世代生物製剤の用途別市場規模2014-2019
（医療、科学研究、その他）
・次世代生物製剤の北米市場：主要企業・種類別/用途別市場規模
・次世代生物製剤のヨーロッパ市場：主要企業・種類別/用途別市場規模
・次世代生物製剤の中国市場：主要企業・種類別/用途別市場規模
・次世代生物製剤の日本国内市場：主要企業・種類別/用途別市場規模
・次世代生物製剤の東南アジア市場：主要企業・種類別/用途別市場規模
・次世代生物製剤のインド市場：主要企業・種類別/用途別市場規模
・次世代生物製剤の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Allergan、Bayer、Biogen Idec、Eli Lilly、Kyowa Hakko Kirin、Molecular Partners、Novo Nordisk、Pfizer、Roche、Sanofi）
・次世代生物製剤の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Next generation biologics refers to some noval drugs, biotreatment and some breakthroght biomaterials etc.The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies.
In 2018, the global Next-Generation Biologics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Next-Generation Biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next-Generation Biologics development in United States, Europe and China.

The key players covered in this study
Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi

Market segment by Type, the product can be split into
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other

Market segment by Application, split into
Medical
Scientific Research
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Next-Generation Biologics status, future forecast, growth opportunity, key market and key players.
To present the Next-Generation Biologics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Next-Generation Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next-Generation Biologics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibodies
1.4.3 Regenerative medicine
1.4.4 Insulins
1.4.5 Growth hormones
1.4.6 Other
1.5 Market by Application
1.5.1 Global Next-Generation Biologics Market Share by Application (2014-2025)
1.5.2 Medical
1.5.3 Scientific Research
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Next-Generation Biologics Market Size
2.2 Next-Generation Biologics Growth Trends by Regions
2.2.1 Next-Generation Biologics Market Size by Regions (2014-2025)
2.2.2 Next-Generation Biologics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Next-Generation Biologics Market Size by Manufacturers
3.1.1 Global Next-Generation Biologics Revenue by Manufacturers (2014-2019)
3.1.2 Global Next-Generation Biologics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Next-Generation Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Next-Generation Biologics Key Players Head office and Area Served
3.3 Key Players Next-Generation Biologics Product/Solution/Service
3.4 Date of Enter into Next-Generation Biologics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Next-Generation Biologics Market Size by Type (2014-2019)
4.2 Global Next-Generation Biologics Market Size by Application (2014-2019)

5 United States
5.1 United States Next-Generation Biologics Market Size (2014-2019)
5.2 Next-Generation Biologics Key Players in United States
5.3 United States Next-Generation Biologics Market Size by Type
5.4 United States Next-Generation Biologics Market Size by Application

6 Europe
6.1 Europe Next-Generation Biologics Market Size (2014-2019)
6.2 Next-Generation Biologics Key Players in Europe
6.3 Europe Next-Generation Biologics Market Size by Type
6.4 Europe Next-Generation Biologics Market Size by Application

7 China
7.1 China Next-Generation Biologics Market Size (2014-2019)
7.2 Next-Generation Biologics Key Players in China
7.3 China Next-Generation Biologics Market Size by Type
7.4 China Next-Generation Biologics Market Size by Application

8 Japan
8.1 Japan Next-Generation Biologics Market Size (2014-2019)
8.2 Next-Generation Biologics Key Players in Japan
8.3 Japan Next-Generation Biologics Market Size by Type
8.4 Japan Next-Generation Biologics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Next-Generation Biologics Market Size (2014-2019)
9.2 Next-Generation Biologics Key Players in Southeast Asia
9.3 Southeast Asia Next-Generation Biologics Market Size by Type
9.4 Southeast Asia Next-Generation Biologics Market Size by Application

10 India
10.1 India Next-Generation Biologics Market Size (2014-2019)
10.2 Next-Generation Biologics Key Players in India
10.3 India Next-Generation Biologics Market Size by Type
10.4 India Next-Generation Biologics Market Size by Application

11 Central & South America
11.1 Central & South America Next-Generation Biologics Market Size (2014-2019)
11.2 Next-Generation Biologics Key Players in Central & South America
11.3 Central & South America Next-Generation Biologics Market Size by Type
11.4 Central & South America Next-Generation Biologics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next-Generation Biologics Introduction
12.1.4 Allergan Revenue in Next-Generation Biologics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next-Generation Biologics Introduction
12.2.4 Bayer Revenue in Next-Generation Biologics Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next-Generation Biologics Introduction
12.3.4 Biogen Idec Revenue in Next-Generation Biologics Business (2014-2019)
12.3.5 Biogen Idec Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next-Generation Biologics Introduction
12.4.4 Eli Lilly Revenue in Next-Generation Biologics Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Kyowa Hakko Kirin
12.5.1 Kyowa Hakko Kirin Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next-Generation Biologics Introduction
12.5.4 Kyowa Hakko Kirin Revenue in Next-Generation Biologics Business (2014-2019)
12.5.5 Kyowa Hakko Kirin Recent Development
12.6 Molecular Partners
12.6.1 Molecular Partners Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next-Generation Biologics Introduction
12.6.4 Molecular Partners Revenue in Next-Generation Biologics Business (2014-2019)
12.6.5 Molecular Partners Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next-Generation Biologics Introduction
12.7.4 Novo Nordisk Revenue in Next-Generation Biologics Business (2014-2019)
12.7.5 Novo Nordisk Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next-Generation Biologics Introduction
12.8.4 Pfizer Revenue in Next-Generation Biologics Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next-Generation Biologics Introduction
12.9.4 Roche Revenue in Next-Generation Biologics Business (2014-2019)
12.9.5 Roche Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next-Generation Biologics Introduction
12.10.4 Sanofi Revenue in Next-Generation Biologics Business (2014-2019)
12.10.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Next-Generation Biologics Key Market Segments
Table Key Players Next-Generation Biologics Covered
Table Global Next-Generation Biologics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Next-Generation Biologics Market Size Market Share by Type 2014-2025
Figure Antibodies Figures
Table Key Players of Antibodies
Figure Regenerative medicine Figures
Table Key Players of Regenerative medicine
Figure Insulins Figures
Table Key Players of Insulins
Figure Growth hormones Figures
Table Key Players of Growth hormones
Figure Other Figures
Table Key Players of Other
Table Global Next-Generation Biologics Market Size Growth by Application 2014-2025 (Million US$)
Figure Medical Case Studies
Figure Scientific Research Case Studies
Figure Other Case Studies
Figure Next-Generation Biologics Report Years Considered
Table Global Next-Generation Biologics Market Size 2014-2025 (Million US$)
Figure Global Next-Generation Biologics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Next-Generation Biologics Market Size by Regions 2014-2025 (Million US$)
Table Global Next-Generation Biologics Market Size by Regions 2014-2019 (Million US$)
Table Global Next-Generation Biologics Market Share by Regions 2014-2019
Figure Global Next-Generation Biologics Market Share by Regions 2014-2019
Figure Global Next-Generation Biologics Market Share by Regions 2019
Table Market Top Trends
Table Global Next-Generation Biologics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Next-Generation Biologics Market Share by Manufacturers (2014-2019)
Figure Global Next-Generation Biologics Market Share by Manufacturers in 2018
Table Global Next-Generation Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next-Generation Biologics Product/Solution/Service
Table Date of Enter into Next-Generation Biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table Global Next-Generation Biologics Market Size Share by Type (2014-2019)
Figure Global Next-Generation Biologics Market Size Market Share by Type (2014-2019)
Table Global Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table Global Next-Generation Biologics Market Size Share by Application (2014-2019)
Figure Global Next-Generation Biologics Market Size Market Share by Application (2014-2019)
Figure Global Next-Generation Biologics Revenue Market Share by Application in 2018
Figure United States Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table United States Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table United States Key Players Next-Generation Biologics Market Share (2018-2019)
Table United States Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table United States Next-Generation Biologics Market Share by Type (2014-2019)
Table United States Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table United States Next-Generation Biologics Market Share by Application (2014-2019)
Figure Europe Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table Europe Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table Europe Key Players Next-Generation Biologics Market Share (2018-2019)
Table Europe Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table Europe Next-Generation Biologics Market Share by Type (2014-2019)
Table Europe Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table Europe Next-Generation Biologics Market Share by Application (2014-2019)
Figure China Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table China Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table China Key Players Next-Generation Biologics Market Share (2018-2019)
Table China Next-Generation Biologics Market Size by Type (2014-20189) (Million US$)
Table China Next-Generation Biologics Market Share by Type (2014-2019)
Table China Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table China Next-Generation Biologics Market Share by Application (2014-2019)
Figure Japan Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table Japan Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table Japan Key Players Next-Generation Biologics Market Share (2018-2019)
Table Japan Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table Japan Next-Generation Biologics Market Share by Type (2014-2019)
Table Japan Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table Japan Next-Generation Biologics Market Share by Application (2014-2019)
Figure Southeast Asia Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Next-Generation Biologics Market Share (2018-2019)
Table Southeast Asia Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Next-Generation Biologics Market Share by Type (2014-2019)
Table Southeast Asia Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Next-Generation Biologics Market Share by Application (2014-2019)
Figure India Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table India Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table India Key Players Next-Generation Biologics Market Share (2018-2019)
Table India Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table India Next-Generation Biologics Market Share by Type (2014-2019)
Table India Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table India Next-Generation Biologics Market Share by Application (2014-2019)
Figure Central & South America Next-Generation Biologics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Next-Generation Biologics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Next-Generation Biologics Market Share (2018-2019)
Table Central & South America Next-Generation Biologics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Next-Generation Biologics Market Share by Type (2014-2019)
Table Central & South America Next-Generation Biologics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Next-Generation Biologics Market Share by Application (2014-2019)
Table Allergan Company Details
Table Allergan Revenue in Next-Generation Biologics Business (2014-2019) (Million US$)
Figure Allergan Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Bayer Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Biogen Idec Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Eli Lilly Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Molecular Partners Company Details
Table Molecular Partners Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Molecular Partners Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Molecular Partners Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Novo Nordisk Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Next-Generation Biologics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Next-Generation Biologics Business (2014-2019)
Table Sanofi Recent Development
Table Global Next-Generation Biologics Market Size by Regions (Million US$) 2019-2025
Figure Global Next-Generation Biologics Market Size Share by Regions (2019-2025)
Figure Global Next-Generation Biologics Market Size Share by Regions in 2025
Figure United States Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure China Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure India Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Next-Generation Biologics Market Size Forecast (2019-2025)(Million USD)
Table Global Next-Generation Biologics Market Size by Product (2019-2025) (Million US$)
Figure Global Next-Generation Biologics Market Size by Product (2019-2025)
Figure Global Next-Generation Biologics Market Size by Product in 2025
Table Global Next-Generation Biologics Market Size by Application (2019-2025) (Million US$)
Figure Global Next-Generation Biologics Market Size by Application (2019-2025)
Figure Global Next-Generation Biologics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 生物製剤アウトソーシングの世界市場：市場規模・現状・予測
    Global Biologics Outsourcing Market Size, Status and Forecast 2019-2025
    QYR9ST12726 2019年9月10日 93Pages
    ※当調査レポートでは、生物製剤アウトソーシングの世界市場について調査・分析し、生物製剤アウトソーシングの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体、組換え、タンパク質、ワクチン、その他）、用...
  • 生物学的安全性試験の世界市場：市場規模・現状・予測
    Global Biologics Safety Testing Market Size, Status and Forecast 2019-2025
    QYR9ST04119 2019年9月2日 98Pages
    ※当調査レポートでは、生物学的安全性試験の世界市場について調査・分析し、生物学的安全性試験の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エンドトキシンテスト
    無菌試験
    細胞...
  • バイオシミラー/生物学的製剤の世界市場：市場規模・現状・予測
    Global Biosimilars/follow-on-biologics Market Size, Status and Forecast 2019-2025
    QYR9ST04725 2019年9月2日 90Pages
    ※当調査レポートでは、バイオシミラー/生物学的製剤の世界市場について調査・分析し、バイオシミラー/生物学的製剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒト成長ホルモン、エリスロポエチン、モノ...
  • 次世代シーケンス（NGS）の世界市場：市場規模・現状・予測
    Global Next Generation Sequencing Market Size, Status and Forecast 2019-2025
    QYR9ST03233 2019年9月2日 104Pages
    ※当調査レポートでは、次世代シーケンス（NGS）の世界市場について調査・分析し、次世代シーケンス（NGS）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ターゲットシーケンシング及びリシーケンシング...
  • 次世代抗体療法の世界市場：市場規模・現状・予測
    Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST04976 2019年9月2日 90Pages
    ※当調査レポートでは、次世代抗体療法の世界市場について調査・分析し、次世代抗体療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体薬物コンジュゲート（ADC）、二重特異性抗体（BsAbs）、Fc...
  • 次世代シーケンス（NGS）の世界市場：市場規模・現状・予測
    Global Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
    QYR9ST03459 2019年9月2日 101Pages
    ※当調査レポートでは、次世代シーケンス（NGS）の世界市場について調査・分析し、次世代シーケンス（NGS）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（消耗品、プラットフォーム、サービス）、用途別...
  • 次世代の糖尿病治療及びドラッグデリバリーの世界市場：市場規模・現状・予測
    Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2019-2025
    QYR9ST03694 2019年9月2日 108Pages
    ※当調査レポートでは、次世代の糖尿病治療及びドラッグデリバリーの世界市場について調査・分析し、次世代の糖尿病治療及びドラッグデリバリーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（吸入インスリン、...
  • 次世代ネットワークの世界市場：市場規模・現状・予測
    Global Next-Generation Network Market Size, Status and Forecast 2019-2025
    QYR9ST03461 2019年9月2日 103Pages
    ※当調査レポートでは、次世代ネットワークの世界市場について調査・分析し、次世代ネットワークの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ハードウェア、ソフトウェア、サービス）、用途別（通信サービス...
  • 臨時発電の世界市場：市場規模・現状・予測
    Global Temporary Power Generation Market Size, Status and Forecast 2019-2025
    QYR9ST14570 2019年9月10日 96Pages
    ※当調査レポートでは、臨時発電の世界市場について調査・分析し、臨時発電の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ディーゼル、ガス、HFO、ガソリン）、用途別（政府及び公益事業、石油及びガス、イ...
  • 次世代パワー半導体の世界市場：市場規模・現状・予測
    Global Next-Generation Power Semiconductors Market Size, Status and Forecast 2019-2025
    QYR9ST04978 2019年9月2日 95Pages
    ※当調査レポートでは、次世代パワー半導体の世界市場について調査・分析し、次世代パワー半導体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（GaN、SiC）、用途別（再生可能エネルギー、ハイブリッド車...